Paragraph 29 F1

A reference to the expiry date printed on the packaging of the product with—

(a)

a warning against using the product after that date;

(b)

if appropriate, details of special storage precautions to be taken;

(c)

if necessary, a warning concerning visible signs of deterioration;

(d)

the full qualitative and quantitative composition;

(e)

the name and address of the UK marketing authorisation holder and, if applicable, the name of the holder's appointed representative; and

(f)

the name and address of the manufacturer.

Annotations

F1: Sch. 27 Pt. 3 inserted (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), regs. 1, 204(6) (as amended by S.I. 2020/1488, reg. 1, Sch. 2 para. 158(e)); 2020 c. 1, Sch. 5 para. 1(1)

F2: Words in Sch. 27 Pt. 3 heading omitted (1.1.2025) by virtue of The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024 (S.I. 2024/832), regs. 1(1), 143(c)